| Literature DB >> 25292108 |
Veronica Vleck1, Gregoire P Millet, Francisco Bessone Alves.
Abstract
Although the sport of triathlon provides an opportunity to research the effect of multi-disciplinary exercise on health across the lifespan, much remains to be done. The literature has failed to consistently or adequately report subject age group, sex, ability level, and/or event-distance specialization. The demands of training and racing are relatively unquantified. Multiple definitions and reporting methods for injury and illness have been implemented. In general, risk factors for maladaptation have not been well-described. The data thus far collected indicate that the sport of triathlon is relatively safe for the well-prepared, well-supplied athlete. Most injuries 'causing cessation or reduction of training or seeking of medical aid' are not serious. However, as the extent to which they recur may be high and is undocumented, injury outcome is unclear. The sudden death rate for competition is 1.5 (0.9-2.5) [mostly swim-related] occurrences for every 100,000 participations. The sudden death rate is unknown for training, although stroke risk may be increased, in the long-term, in genetically susceptible athletes. During heavy training and up to 5 days post-competition, host protection against pathogens may also be compromised. The incidence of illness seems low, but its outcome is unclear. More prospective investigation of the immunological, oxidative stress-related and cardiovascular effects of triathlon training and competition is warranted. Training diaries may prove to be a promising method of monitoring negative adaptation and its potential risk factors. More longitudinal, medical-tent-based studies of the aetiology and treatment demands of race-related injury and illness are needed.Entities:
Mesh:
Year: 2014 PMID: 25292108 PMCID: PMC7099231 DOI: 10.1007/s40279-014-0244-0
Source DB: PubMed Journal: Sports Med ISSN: 0112-1642 Impact factor: 11.136
Selected potential intrinsic and extrinsic factors for maladaptation that have been found to vary with sex, distance specialization and ability in triathletes (reproduced from Vleck [12], with permission)a
| Variable | Ability | Event distance | Sex | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E OD M vs. SE OD M | E OD M vs | SE OD M vs. NE OD M | E OD F vs. SE OD F | OD vs. IM | E OD M vs. E IM M | SE OD M vs. E IM M | E OD F vs. E IM F | SE OD F vs. E IM F | M vs | E IM vs | E OD M vs | SE OD M vs | ||
| Competitive experience (years) | Swim | – | – | – | * | – | * | * | ** | – | – | – | – | – |
| Cycle | *** | – | – | – | – | – | – | – | – | – | – | – | – | |
| Run | *** | – | – | – | – | – | – | * | – | – | – | – | – | |
| Triathlon | *** | – | – | – | – | – | *** | – | – | – | – | – | – | |
| Psychological state | Sad or depressed | – | – | – | – | – | – | – | – | – | – | – | – | * |
| Stressed | – | – | – | ** | – | – | – | – | – | ** | – | – | ** | |
| Tense/anxious | – | – | – | – | – | – | – | – | – | – | – | – | * | |
| Worried | – | – | – | – | – | – | – | – | – | ** | – | – | – | |
| Restless sleep | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Cannot cope | – | – | – | * | – | – | – | – | – | ** | – | – | *** | |
| Need to get away | – | – | – | – | – | – | – | – | – | – | – | – | ** | |
| Mood disturbance | – | – | – | * | – | – | – | – | – | – | – | – | ** | |
| Level reached in cycling | – | – | – | – | – | – | – | – | – | – | * | – | – | |
| Best distance | – | – | – | – | – | *** | – | – | – | – | – | – | – | |
| Orthopaedic problems | – | – | – | – | – | * | – | – | – | – | – | – | – | |
| Weekly training time (h) | Running | ** | – | – | – | – | – | – | – | – | – | – | – | – |
| Long runs | *** | – | – | * | – | – | – | ** | – | – | – | – | – | |
| Overall | – | – | – | – | – | – | – | * | – | – | – | – | * | |
| Weekly training distance (km) | Overall | *** | – | – | – | *** | – | * | – | – | – | – | – | *** |
| Swimming | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Cycling | *** | – | – | – | – | – | – | – | – | – | – | – | – | |
| Running | *** | – | – | – | *** | – | – | – | – | ** | – | – | – | |
| Number of sessions per week | Swimming, cycling and running | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Swimming (overall) | – | – | – | – | – | – | – | – | – | ** | – | – | – | |
| Cycling (overall) | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Running (overall) | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Speed work bike | – | – | – | – | * | – | – | – | – | – | * | – | – | |
| Hill repetition cycle sessions | – | – | – | – | – | – | – | – | – | ** | – | – | – | |
| Back-to-back cycle run training | * | – | – | – | – | – | – | – | – | – | – | – | – | |
| Hill repetition run sessions | – | – | – | – | – | – | – | – | – | ** | – | – | – | |
| Long runs | – | – | – | – | * | – | – | – | – | – | – | – | – | |
| Other types of run session | – | – | – | – | – | – | – | – | – | ** | – | – | – | |
| Length of each session | Each long cycle | – | – | – | – | * | – | – | – | – | – | – | – | – |
| Each long run | – | – | – | – | * | – | – | – | – | – | – | – | – | |
| Warm up/warm down | Pre-swim | – | – | – | – | ** | – | – | – | – | – | – | – | ** |
| Post-swim | – | – | – | – | – | – | – | – | – | ** | – | – | – | |
| Pre-cycle | – | – | – | – | – | * | – | – | – | – | * | – | – | |
| Post-cycle | – | – | – | – | * | * | – | – | – | – | – | – | – | |
| Stretching | Pre-swim | – | – | – | – | * | – | – | – | – | – | – | – | * |
| Post-cycle | – | – | – | – | – | * | – | – | * | – | – | * | * | |
| Pre-run warm-up | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Technique analysis | Swim | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Run | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Transition | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Train with single-sport athletes | Swim | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Cycle | – | – | – | * | *** | * | – | – | * | – | – | – | – | |
| Run | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Type of coach | Cycle | – | – | – | – | – | – | – | – | – | *** | * | – | – |
| Run | – | – | – | – | – | – | – | – | – | *** | * | – | – | |
| Periodised trainingb | *** | – | – | – | – | – | – | – | – | – | – | – | – | |
indicates no information, E 1994 elite (most likely corresponding to higher ability, well-trained recreational athletes of today), IM Ironman distance (i.e. 3.8-km swim, 180-km cycle, 42.2-km run), F female, M male, NE non-elite (recreational) athletes, OD Olympic distance (i.e. 1.5-km swim, 40-km cycle, 10-km run), SE 1994 sub-elite (most likely corresponding to good, well-trained, recreational athletes of today
* p < 0.05, ** p < 0.02, *** p < 0.01 from the group marked with the same symbol and in the same row of the table
aNo differences were observed between the various groups in the use of clipless pedals, use of different types of cycle handlebars or gearshift systems
bFor the entire year as opposed to from race to race
Fig. 1Changes in distribution of training intensity of Olympic-distance triathletes over a two-peak competitive season: (a) swim, (b) bike, (c) run (reproduced from Vleck [12], with permission.) EB endurance base, Pre-comp pre-competition, Comp competition, S swim, B bike, R run, L intensity level (rated as 1–5, with 1 being the lowest intensity)
Fig. 2Changes in weekly rates of total training stress (arbitrary units) across consecutive macro-cycles of a two-peak competitive season in Olympic-distance triathletes: (a) swim, (b) bike, (c) run (reproduced from Vleck [12], with permission). EB endurance base, T transition, PC pre-competition, C competition, S swim, B bike, R run, L intensity level (rated as 1–5 with 1 being the lowest intensity)
Physiological demands of (actual or simulated) triathlon competition (values expressed as mean ± SD)a
| Study | Distance | Percentage of maximal oxygen uptakeb | Percentage of maximal heart rate | Percentage of maximal aerobic speed/maximal aerobic power/peak running speed | |||||
|---|---|---|---|---|---|---|---|---|---|
| Cycle | Run | Swim | Cycle | Run | Swim | Cycle | Run | ||
| Taylor et al. [ | Simulated sprint (lab)c | 82.1 ± 6.0 | 89.7 ± 4.9 | – | 89.6 ± 3.5 | 91.9 ± 1.9 | – | 68.2 ± 7.2 | 87.5 ± 3.0 |
| Binnie et al. [ | Simulated sprint (lab)c | – | – | – | – | – | – | – | – |
| Gonzalez-Haro et al. [ | Simulated OD swim-cycle (lab) | 82.8 | – | – | 92 | – | 98 ± 2 | 77 ± 10 | – |
| Bernard et al. [ | OD (field)d | – | – | – | 91 ± 4 | – | – | 60 ± 8 | – |
| Le Meur et al. [ | OD (field)d | – | – | – | 92 ± 3 F 92 ± 2 | – | – | 63.4 ± 6.5 F 61 ± 7.5 | – |
| Gillum et al. [ | ½ IMe | 68 | 70 | – | – | – | – | – | – |
| Laursen et al. [ | IMe | – | – | 80 | – | – | – | – | – |
– indicates no information, F female, ½ IM half-Ironman (i.e. 1.9-km swim, 90-km cycle, 21-km run), IM Ironman distance (i.e. 3.8-km swim, 180-km cycle, 42.2-km run), lab laboratory, OD Olympic distance (1.5-km swim, 40-km cycle, 10-km run), SD standard deviation
aAll values in the table refer to males unless otherwise specified
bNo swim-related data are available
cIn both cases, the cycle section involved a 500 kJ (approximately 20 km) task
dDraft-legal (i.e. in which slip-streaming behind another cycle(s) is allowed within the cycle section)
eNon-drafting
Immunological, oxidative and cardiovascular responses to triathlon training
| Study | Athlete level | Marker type | Marker | Measure | Result |
|---|---|---|---|---|---|
| Diaz et al. [ | 17 elite | White blood cell count | – | Season start, pre-competition, start and end of race period for four consecutive seasons | Non-significant effect of period, season or season period. Neutropenia in 8, monocytopenia in 9, and lymphopenia in 1 at some point |
| Horn et al. [ | 48 healthy rested elites | – | Overnight ‘at rest’ sample. Comparison across multiple sports. | Neutropenia (<2 × 109/L) in 16 %, monocytopenia (<0.2 × 109) in 5 % | |
| Cosgrove et al. [ | 10 recreational IM | Changes in peripheral differentiated and senescent T cells | – | 27, 21, 15, 9 and 3 weeks (June) prior to and 2 weeks post-race | 1 % ↑ of differentiated (KLRG1+/CD57−) CD8+ T cells and ‘transitional’ (CD45RA+/CD45RO+) CD4+ and CD8+ T cells with training. Two weeks post-race: differentiated CD8+ T cells at T0 level, ↑ senescent CD4+ T cells, ↓ naïve (CD45RA+/CD45RO) cells |
| Pool et al. [ | 13 M tri, 8 M recreationally active controls | Immune function | Endotoxin induced IL-6 release in whole blood cultures | 24 h post-exercise | [Tri-plasma IL-6] and in vitro [basal IL-6] and [endotoxin activated IL-6] > that of controls. Post-endotoxin: [newly induced IL-6] in tri < in controls |
| Broadbent [ | 15 IM, 12 UT controls | Haematology, CD4(+) lymphocyte transferrin receptor (CD71) expression, CD4(+) intracellular iron and URTI | – | Every 4 weeks for 1 year | Tri < control values for Hb (10 months), MCHC (9 months), platelet (11 months) and CD4(+)CD71(+) (1 month). Tri < controls for CD4(+)CD71(+) [3 months]; Fe(3+) [1 month]. Less URTI in tri |
| Rietjens et al. [ | 7 M, 4 F elite | Haematology | Hb, haematocrit, erythrocyte count, mean corpuscular Hb content, mean corpuscular volume and plasma ferritin | 102 samples over 3 years | Erythrocyte count ↓ in race compared with training season. Hematological values < lower limit of normal range in off-, training- and race-season in 46, 55 and 72 %, respectively |
| Gouarne et al. [ | 9 UT, 10 tri | Hormonal parameters | Salivary cortisol response to waking, overnight urinary cortisol, cortisone and catecholamine excretion | 10-month season | Overnight urinary cortisone excretion for tri > UT |
| Knez et al. [ | 16 ½IM, 29 M age-matched healthy controls | Oxidative stress and antioxidant status | [MDA]; GPX, CAT and superoxide dismutase activity | – | ½IM resting GPX > controls. IM resting plasma [MDA] < controls, IM GPX and CAT > controls |
| Medina et al. [ | 5 F, 10 M | Oxidative stress markers and prostaglandin metabolites | – | Pattern of isoprostane and prostaglandin metabolites in urine post-training | ↓ [Tetranor-PGEM and 11beta-PGF(2alpha)] and [IsoP 8-iso-PGF(2alpha)]. ↑ (vascular PGI2 metabolite). Variation possibly linked to training |
| Banfi et al. [ | 7 elite, 5 controls | Growth factors and chemokines | VEGF, EGF, MCP-1, IL-8 | T0: 1-day pre-race season start | Tri EGF and IL-8 > control EGF |
| T1: 30-min post-tri | Tri VEGF, EGF, MCP-1 and IL-8 > control VEGF, EGF, and MCP-1 | ||||
| Konig et al. [ | 42 M | Homocysteine levels | Plasma [total Hcy], [vitamin B(12)], and [folic acid] | Pre- and post 30 days training, pre- and post-sprint tri | No change in Hcy post-training. [Folate] > in high-training group post-training |
| Diaz et al. [ | 5 elite M | Overtraining parameters 5 weeks up to major race vs | Total testosterone, CK, urea, total cortisol | Wednesday and Thursday of 1-week microcycles with high loads on Monday, Tuesday, Friday and Saturday | Urea and CK over 4/5 loading weeks > T0 values |
| Spence et al. [ | 32 elite, 31 AG tri and cyclists, 20 UT controls | Respiratory health | URTI | Nasopharyngeal and throat swabs for subjects with two or more URTI symptoms over 5 months | 37 URTI episodes in 28 subjects. Infectious agents seen in 11 (2 control, 3 AG and 6 elite). Incidence rate ratios for illness in controls and elites > AG |
| Knopfli et al. [ | 7 elite | FEV1 extrapolation of decrease in FEV1 to BH limit | 8-min track run at intensities equal to anaerobic threshold. Tests at 4.4 ± 2.8 °C, −8.8 ± 2.4 °C and 3.6 ± 1.5 °C, and humidity of 52 ± 16, 83 ± 13 and 93 ± 2 % | BH ↑ within 2 years. Three athletes with BH. After extrapolation of the decrease in FEV1, it was determined that 21–57 % of athletes had newly developed BH per year | |
| Claessens et al. [ | 52 tri, 22 controls | Structural and functional cardiac adaptations | Ventricular premature beat incidence | Number of VPB within last 2 min of maximal exercise tests on treadmill and bidirectional two-dimensional echo-doppler exam for five consecutive beats | Tri > controls for VPB and late passive diastolic filling period amplitude of excursion of the interventricular septal endocardium at the end of the LV diastole just after atrial contraction values. Tri < controls for (P top-onset systolic septal contraction) interval and P top-LV posterior wall systolic contraction interval. Tri had more incomplete right bundle block. Tri: concentric and eccentric hypertrophy and evidence of supernormal diastolic LV function. Tri max diastolic LV and RV internal diameter, diastolic interventricular septum thickness and diastolic LV posterior wall thickness > controls. It was not always the best tri who had the most significant structural cardiac adaptations |
| Douglas et al. [ | 26 tri, 17 controls | M-mode LV echograms and doppler recordings of LV inflow velocity | – | Tri > controls for LV wall thickness, relative wall thickness, LV mass and doppler-derived ratio of early-to-late LV inflow velocities. No difference in resting systolic function, diastolic LV fractional shortening or end systolic stress | |
| Knez et al. [ | 44 tri, 44 active controls | Brachial BP, central haemodynamics (↑ aortic BP, wave reflection, augmentation index, ejection duration, timing of reflected wave | – | No significant difference for augmentation index, timing or reflected wave, brachial or central pulse pressure. Tri > controls for sub-endocardial perfusion capacity, sub-endocardial perfusion and ejection duration | |
| Scharf et al. [ | 26 elite M, 27 non-athletic M controls | Indexed LV and RV myocardial mass, end-diastolic and end-systolic volumes, stroke volume, ejection fraction, and cardiac index at rest; ventricular remodelling index and maximum LA volume | – | Combination of eccentric and concentric remodeling with regulative ↑ of atrial and ventricular chambers. Tri atrial and ventricular volume and mass indexes > controls. Tri LV and RV end-diastolic volumes > normal range in 25/26) Findings different from other types of elite | |
| Platen et al. [ | 18 tri, 69 UT/trained student controls | Bone health | BMD | Athletes vs | Lumbar spine, femoral neck, trochanter major and intertrochanteric BMD < trained controls. Femoral neck and Ward’s triangle values > UT |
| Shellock et al. [ | 20 M, 9 F | Knee cartilage abnormalities | – | Abnormal MRI findings no greater than age-related changes for other athletic populations and UT | |
| Smith and Rutherford [ | 8 tri, 13 UT | Regional bone density | – | No difference in spine and total BMD between tri and controls. Serum testosterone < in tri | |
| McClanahan et al. [ | 9 M, 12 F | Total body, arms and leg BMD | Just before and immediately after 24-week competitive season | No adverse changes in BMD | |
| Muhlbauer et al. [ | 9 tri, 9 inactive controls | Knee joint cartilage thickness | Via nuclear MRI | No significant difference between groups in patella, femoral trochlea, lateral femoral condyle, medial femoral condyle, medial and lateral tibial plateau cartilage thickness | |
| Maimoun et al. [ | 7 M | Bone metabolism, bone turnover; sexual, calciotropic and somatotropic hormones | Total and regional BMD, bone-specific alkaline phosphatase, osteocalcin, and urinary type I collagen C-telopeptide | Start of training and 32 weeks later | ↑ BMD for lumbar spine and skull but not total body or proximal femur, ↑ 1alpha,25-dihydroxyvitamin D3, insulin-like growth factor-1 and bioavailability of insulin-like growth factor-1 index. ↓ Bone-specific alkaline phosphatase. No change in parathyroid hormone, [testosterone], [insulin-like growth factor-binding protein-3] and [cortisol] |
| Newsham-West et al. [ | 8 M and 7 F sub-elite, 17–23 years | Tibial morphology | Medial, anterior and lateral cortex thickness. Oedema/stress fracture on nuclear MRI | Comparison of stress fracture and non-stress fracture groups | Significantly different medial cortex thickness between groups. Those with oedema within the cancellous bone or a stress fracture on MRI took time off within 2 years due to stress fracture |
| Lucia et al. [ | 9 Elite | Reproductive health | Percentage body fat, hormonal profile (resting levels of follicle-stimulating hormone, luteinizing hormone, total and free testosterone, and cortisol), and seminograms | Three times within season (winter, competitive, and rest period) | Triathlon training does not adversely affect hypothalamic-pituitary-testis axis |
| Vaamonde et al. [ | 45 including tri | Sperm parameters (volume, liquefaction time, pH, viscosity, sperm count, motility, and morphology) | – | Morphology reaching clinical relevance for tri. Parameters tended to ↓ as training ↑ |
– indicates no information, ↓ indicates decrease, ↑ indicates increase, [] concentration, AG age-groupers, i.e. non-elite athletes who compete against other athletes within the same 5-year age range, BH bronchial hypereactivity, BMD bone mineral density, BP blood pressure, CAT catalase, CK creatine kinase, EGF extracellular growth factor, F female, FEV forced expiratory volume in 1 s, GPX glutathione peroxidase, Hb haemoglobin, Hcy haemocyanin, IsoP isoproterenol, IL interleukin, IM Ironman (i.e. 3.8-km swim, 180-km cycle, 42.2-km run), ½IM half-Ironman (i.e. 1.9-km swim, 90-km cycle, 21-km run), LA left atrial, LV left ventricular, M male, MCHC mean corpuscular hemoglobin content, MCP-1 monocyte chemoatractant protein-1, MRI magnetic resonance imaging, PGEM prostaglandin E2 metabolite, PGF prostaglandin F, PGI prostaglandin I2, RV right ventricle, T0 baseline, tri triathlete, URTI upper respiratory tract infection, UT untrained, VEGF vascular endothelial growth factor, VPB ventricular premature beats
Risk factors for injury that have been directly assessed in the triathlon literature (modified and updated from Vleck [202], with permission)
| Possible risk factor | Injury variable | Significant relationship (at the 95 % confidence level or higher) observed between risk factor and injury variable | |
|---|---|---|---|
| Yes | No | ||
| Sex | Overuse injury occurrence | Vleck [ | Collins et al. [ |
| Number of injuries | – | Vleck [ | |
| Age | Injury occurrence | Egermann et al. [ | Collins et al. [ |
| Height | Injury occurrence | – | Vleck and Garbutt [ |
| Body mass index | Injury occurrence | – | Collins et al. [ |
| COL5A1 CC1 genotype | Exercise-associated muscle cramping | O’Connell et al. [ | – |
| Foot type, orthopaedic problems | Injury occurrence | Burns et al. [ | Vleck [ |
| Orthopaedic problems | Overuse injury incidence | – | Vleck and Garbutt [ |
| Previous injury | Injury incidence | Korkia et al. [ | Manninen and Kallinen [ |
| Achilles tendon, hamstring, knee and lower-back injury | Calf injury occurrence | Vleck and Garbutt [ | – |
| Diet | Injury occurrence | – | Vleck and Garbutt [ |
| Use of NSAIDs | Hyponatremia | Wharam et al. [ | – |
| Restless sleeper, restless sleep, health worries | Overuse injury incidence | – | Vleck and Garbutt [ |
| Psychological state/total mood disturbance (basic analysis)/daily or weekly hassles | Overuse injury incidence | Fawkner et al. [ | Vleck and Garbutt [ |
| Position on cycle/degree of trunk flexion on cycle/use of aerobars | Overuse injury incidence | – | Vleck and Garbutt [ |
| Cycle gear ratio/crank length | Cycle injury | – | Massimino et al. [ |
| Use of and type of clipless pedals | Overuse injury incidence | – | Vleck and Garbutt [ |
| Cycle cadence | Overuse injury incidence | – | Massimino et al. [ |
| Cycling cadence trained at | Overuse injury incidencee | – | Massimino et al. [ |
| Faulty running shoe construction | Plantar fasciitis | Wilk et al. [ | – |
| Training in other sports | Overuse injury incidence | Collins et al. [ | Manninen and Kallinen [ |
| Sporting background | Injury occurrence | Williams et al. [ | Vleck and Garbutt [ |
| Initial sporting background | Overuse injury incidenced | Williams et al. [ | Collins et al. [ |
| Level reached in single sport | Injury incidence | – | Vleck [ |
| Years of competitive experience | Injury occurrence | Burns et al. [ | Vleck [ |
| Injury incidence | Korkia et al. [ | Vleck and Garbutt [ | |
| Years of competitive swimming or cycling experience | Vleck [ | ||
| Years of competitive running experience | Number of running injuries | Vleck [ | Vleck [ |
| Number of triathlons participated in/years of triathlon experience | Low BP or neck pain | Villavicencio et al. [ | Collins et al. [ |
| Athletic status | Overuse injury incidence | – | Collins et al. [ |
| Athlete ability level | Injury incidence | Shaw et al. [ | Korkia et al. [ |
| Performance level | Injury incidence | Egermann et al. [ | Zwingenberger et al. [ |
| Personal best time | Injury to specific anatomical site | – | Vleck and Garbutt [ |
| Main competitive distance | Injury occurrence | Williams et al. [ | Korkia et al. [ |
| Race distance trained for | Overuse injury incidenced | (For anatomical location) Vleck [ | Vleck 2010 [ |
| Race distance done | Medical assistance | Gosling et al. [ | Gosling et al. [ |
| Race distance (IM vs | Hyponatremia prevalence | Rust et al. [ | – |
| Degree and specificity of coaching and feedback | Overuse injury incidenced | – | Collins et al. [ |
| Back-to-back cycle run transition training (yes/no) | Overuse injury incidenced | – | Vleck and Garbutt [ |
| Presence of medical care (yes/no) | Injury | – | Egermann et al. [ |
| Presenting for medical aid in race (yes/no) | Injury incidence | Gosling et al. [ | – |
| Stretching practice/flexibility | Injury incidenced | Negative, Massimino et al. [ | Ireland and Micheli [ |
| Warm-up/cool-down practice | Number of injuries | Burns et al. [ | Ireland and Micheli [ |
| Warm-down/stretching after training | Overuse injury incidenced | – | Vleck and Garbutt [ |
| Cool-down practiced (yes/no) | Number of injuries | – | Korkia et al. [ |
| Altered blood flow | Gastrointestinal symptoms | – | Wright et al. [ |
| Number of races per season/participation in competition/time spent competing | Overuse injury incidenced | Zwingenberger et al. [ | Villavicencio et al. [ |
| Training time | Injury incidenced | Egermann et al. [ | Villavicencio et al. [ |
| Time spent cycling | Number of cycling injuries | Vleck and Garbutt [ | – |
| Time spent running | Number of running injuries | Vleck [ | – |
| Number of cycling injuries | Vleck and Garbutt [ | – | |
| Time spent running | Occurrence of Achilles tendon injuries | Vleck [ | – |
| Time spent doing long runs | Number of running injuries | Vleck [ | Vleck [ |
| Amount or percentage of training time spent in each discipline | Injury incidenced | – | Ireland and Micheli [ |
| Average time doing intervals, hard, moderate, easy and hill training in all disciplines combined | Injury incidenced | – | Korkia et al. [ |
| Total time spent doing speed cycle work during a race week without taper | Number of injuries | Vleck [ | – |
| Lower-back injury prevalence | Vleck [ | – | |
| Percentage of (cycle) training spent doing interval work | Number of overuse injuries | Vleck [ | O’Toole et al. [ |
| Percentage of time spent or number of sessions spent doing cycle hill repetitions | Number of injuries | Vleck [ | Massimino et al. [ |
| Time out of seat during training sessions | Number of injuries | – | Massimino et al. [ |
| Percentage of time spent or number of sessions spent doing run hill repetitions | Number of injuries | Vleck [ | – |
| Increased percentage of time spent doing quality or track run work | Number of injuries | Vleck [ | Massimimo et al. [ |
| Training distance | Number of (cycling) injuries | – | Ireland and Micheli [ |
| Number of run overuse injuries | Vleck [ | – | |
| Injury incidenced | Burns et al. [ | Massimino et al. [ | |
| Swimming distance | Number of run injuries | Vleck and Garbutt [ | – |
| Overdistance swim work, fartlek, hypoxic, kick, pull in swim | Incidence of swimming injuries | – | Massimino et al. [ |
| Weekly cycling distance | Number of injuries | Williams et al. [ | – |
| Number of run injuries | Vleck and Garbutt [ | – | |
| Cycling overdistance, pace, cadence | Number of cycling injuries | – | Massimino et al. [ |
| Increased cycle overdistance work | Number of cycling injuries | – | Massimino et al. [ |
| Distance covered during run hill repetitions | Occurence of Achilles tendon injuries | Vleck [ | – |
| Higher pre-season running mileage | Number of injuries | Burns et al. [ | – |
| Mileage for week before event | KI incidenced | – | Massimino et al. [ |
| Number of triathlon workouts per week | Injury incidenced | Vleck and Garbutt [ | Korkia et al. [ |
| Number of ‘other’ (than speed, long or hill repetition) cycle sessions per week | Number of overuse injuries | Vleck[ | Vleck [ |
| Number of other types of cycle session, increased percentage of time sent doing cycle interval work | Number of injuries | Vleck [ | – |
| Number of run sessions per week | Number of run injuries | Vleck and Garbutt [ | – |
| Number of run speed sessions | Injury incidenced | Vleck [ | – |
| Number of hill repetition run sessions per week | Number of overuse injuries | Vleck [ | – |
| Number of other (i.e | Injury incidenced | Vleck [ | – |
| Long-run session time | Injury incidenced | Vleck [ | – |
| Number of running injuries | Vleck [ | Vleck [ | |
| Duration of speed run sessions | – | Vleck [ | Vleck [ |
| Training sequence | Injury/KI incidenced | – | Massimino et al. [ |
| Strength training (yes/no) | Overuse injury incidenced | – | Korkia et al. [ |
| Combined intensity work for all three disciplines | Injury incidenced | – | Korkia et al. [ |
| Pace/intensity (not in detail) | Injury incidenced | Vleck [ | Massimino et al. [ |
| Increase in training load | Injury incidenced | Vleck [ | Korkia et al. [ |
| Cycled faster | Foot, ankle, Achilles tendon injury | – | Massimino et al. [ |
| Increased other (i.e. not long, hill repetition or speed) cycle training | Foot, ankle, Achilles tendon injury | Vleck [ | – |
| Weighted combined cycle and run training in intensity levels 3–5 of 5 (with level 5 being the highest intensity) | Injury incidenced | Vleck [ | – |
– indicates no information, Ach Achilles tendon, Ank ankle, B bicycling, BP back pain, CP cervical pain, E 1994 elite (probably most similar to very-well-trained recreational athletes), F female, IM Ironman (i.e. 3.8-km swim, 180-km cycle, 42.2-km run), K knee, KI knee injury, LB lower back, M males, NE non-elite, NP neck pain, NSAIDs non-steroidal anti-inflammatory drugs, OD Olympic distance (i.e.1.5-km swim, 40-km cycle, 10-km run), Pros prospective study, R running, Rec recreational, Retros retrospective study, RI running injuries, S wimming, SE 1994 sub-elite (probably most similar to good age-groupers, i.e. athletes competing within their 5-year age-group band, of today), SBR swim, bike and run, T triathlon
* p < 0.05, ** p < 0.02, *** p < 0.001
aVery limited data. Potential links between diet/disordered eating/occurrence of female athlete triad and triathlon injury have not yet been investigated
bValue correlation coefficient not given because it was calculated for a three-sport sample
cPrevious lower-limb pain was not linked to the onset of lower-back pain
dUnless a prospective study, most incidence data actually refer to incidence proportions
eLumbar pain linked with prior foot, ankle or knee injury
fSome indication of a sex, age, event distance and or athlete ability/experience effect seen in this study
Selected studies that have related physiological, cardiovascular, immunological, neuromuscular, endocrinological and/or psychobiological markers to triathlon performance, non-functional overreaching, burnout or overtraining
| Study | Group | Design | Markers | Result |
|---|---|---|---|---|
| de Milander et al. [ | 468 IM M, 200 M controls | Genotype comparison of fastest, middle and slowest IM finishers, and controls | IL-6 −174 G/C, 5-HTT 40 base-pair insertion–deletion, 30 base-pair variable number of tandem repeat MAO-A gene polymorphisms | No direct associations between IL-6 −174 G/C, 5-HTT 44 base-pair insertion–deletion, and MAO-A 30 base-pair variable number of tandem repeat gene polymorphisms and endurance perf, although central governor theory implies IL and serotonin levels play a role in endurance capacity |
| Van Schuylenbergh et al. [ | 10 | Cycle- and run-graded maximal exercise test, two to three 30-min constant-load tests in swimming, cycling and running to establish their maximal lactate steady state. Sprint race 2-weeks post | HR, power output or running/swimming speed and [BLA] at regular intervals. Oxygen uptake | Stepwise multiple regression analysis run speed and swim speed at maximal lactate steady state, and [BLA] at run maximal lactate steady state, best prediction of perf |
| Hue [ | 8 elite M | Stepwise multiple regression of links between OD draft legal time and variables within a laboratory 30-min cycle, 20-min run trial | [BLA] | Predicted triathlon time (s) = 1.128 (distance covered during run of cycle-run time-trial [m]) + 38.8 ([BLA] at end of cycle in cycle run time-trial) + 13,338 |
| Laursen et al. [ | 21 | Correlation between IM perf, HR and HR at various laboratory-based cycle or run thresholds |
| Mean HR during cycle and run of IM related to ( |
| Schabort et al. [ | 5M, 5F elite | Correlation of laboratory test variables 4 days post OD race with maximal swimming test results over 25 and 400 m, bike peak power output, bike | Cycle PPO, cycle VO2peak, run Vmax, run VO2peak, 25- and 400-m swim time. Steady state VO2, HR and [BLA] during cycle and run laboratory tests | Five most significant predictors of triathlon perf were [BLA] at 4 W kg−1, run [BLA] at 15 kph, run Vmax, and cycle |
| Millet and Bentley [ | 7 M juniors, 6 F juniors, 9 senior M, 9 senior F | Correlation between laboratory (submaximal treadmill run 1, maximal then submaximal cycle, submaximal treadmill run 2) variables and OD perf | Run 1 EC, cycle PPO, cycle | Overall triathlon time (min) correlated with cycle V02max ( |
| Millet et al. [ | 15 elite M | As above | – | Swimming time correlated with |
| Miura et al. [ | 17M | Correlation between OD perf and simulated laboratory triathlon (30-min swim, 75-min cycle, 45-min run, all at 60 % | VO2peak and EC in each discipline | OD triathlon (total time) correlated with swim |
| Rietjens et al. [ | 7 M | Correlation tested pre and post 2-week period of training load (i.e. 200 % prior volume and 115 % prior intensity) | Maximal incremental cycle ergometer test with continuous ventilatory measurements and [BLA] values, time trial, basal blood parameter tests (red and white blood cell profile), growth hormone, insulin-like growth factor 1, adrenocorticotropic hormone, [cortisol], neuroendocrine stress test [short insulin tolerance test, combined anterior pituitary test and exercise], a shortened POMS, RPE and cognitive reaction time test | ↑Training period resulted in ↑ training load, training monotony and training strain. RPE during training ↑, total mood score ↑. Reaction times ↓. No changes in exercise-induced plasma hormone values, nor short insulin tolerance test values. During the combined anterior pituitary test only cortisol ↓ after intensified training. Hb ↓, Hct, red blood cell count and mean corpuscular volume tended to ↓. No effect on physical performance (incremental test or time trial), maximal blood lactate, maximal heart rate and white blood cell profile. The most sensitive parameters for detecting overreaching are reaction time performance, RPE and the shortened POMS |
| Robson-Ansley et al. [ | 8 M | 4 weeks training, including 3 successive days of intensified run interval training in weeks 2 and 3. Saliva and blood sampling 1 × week−1 | Leukocyte counts; neutrophil function; plasma IL-6; CK activity; and cortisol. Signs and symptoms of stress | Plasma IL-6 and CK activity ↑ after intense training. Neutrophil function ↓ but total leukocyte and neutrophil counts, plasma cortisol and salivary immunoglobulin A unchanged. ↑ Symptoms of stress despite no change in sources of stress during training |
| Seedhouse et al. [ | 8 | Day 1: 10-km swim, 165-km cycle; day 2: 261-km cycle; day 3: 85-km run. Baseline HR, MAP and pulmonary function 2 days pre-race. HR and MAP <30 min prior to race start and 10 min post. Pulmonary function immediately post-race | HR, MAP and pulmonary function | Lower baseline resting HR correlated with faster race times. ↓ FEV1 and peak expiratory flow over race correlated with perf. HR and MAP had strongest association with total race time prediction (54 and 19 % of total). When ↓ in pulmonary function included, peak expiratory flow associated with 87 % of total race time prediction |
| Gratze et al. [ | 27 M | Multivariate regression analysis of beat-to-beat hemodynamic and autonomic parameters for supine rest and active standing pre, 1 h post and up to 1 week post IM | HR, SBP, DBP, TPRI | 0.05–0.17 Hz band of diastolic blood pressure variability before competition and weekly net exercise training, but not the other hemodynamic and autonomic parameters, related to perf time |
| Balthazar et al. [ | 8 M professional | Correlation between salivary data on competition day, 7 days post, and short tri perf | Cortisol, testosterone | Early morning cortisol, not testosterone/cortisol ratio, correlated with perf |
| Del Coso et al. [ | 25 well-trained M | Correlation between jump height and leg muscle power for countermovement jump pre and post ½IM with muscle damage | CK, myoglobin | Leg-muscle fatigue correlated with blood markers of muscle damage |
| Margaritis et al. [ | 12 racing, 5 not | Correlation between serum enzyme activity and markers of muscle damage, from 2 days prior to 4 days post LD competition | Maximum voluntary contraction, DOMS, and total serum CK, CK myoglobin isoenzyme, LDH, aspartate aminotransferase and alanine aminotransferase activities | Extent of and recovery from muscle damage cannot be evaluated by magnitude of changes in serum enzyme activities. Muscle enzyme release cannot be used to predict magnitude of muscle function impairment caused by muscle damage |
| Medina et al. [ | 10 M, 5 F | Pattern of iso-prostanes and prostaglandin metabolites in urine after triathlon training | – | Variation in 6-keto PGF(1 alpha) after exercise is linked to their precursor prostaglandin: a useful marker of vasodilation and inhibition of platelet aggregation |
| Sharwood et al. [ | 258 IM | Establish relationships between body weight changes and serum sodium concentration during and after IM, and post-race fluid status, rectal temperature, including the incidence of hyponatremia. Weighed at registration, immediately pre-race, immediately post-race, and 12 h later. Blood samples at registration and immediately post-race. Rectal temperatures measured post-race. BP and [serum sodium] at registration and immediately post-race. Rectal temperatures and medical exam post-race | – | Percentage change in body weight linearly related to post-race serum sodium concentrations but unrelated to post-race rectal temperature or running perf in the marathon. No evidence that more severe levels of weight loss or dehydration related to either body temperatures or ↓ perf. Large changes in body weight not associated with prevalence of medical complications or rectal temperatures but associated with serum sodium concentrations |
| Millet et al. [ | 4 elite | Effects of training load (calculated from exercise HR) on anxiety and perceived fatigue, over 40 weeks | Anxiety and perceived fatigue self-reported 2 × week−1 | Relationship ( |
| Barnett et al. [ | 1 elite F | Retrospective examination, via dynamic linear models and mediating variable analysis, of case study data of association of training load with SE | SE (perf.) via RESTQ-Sport (2 × week−1 for 137 days); fatigue/‘lack of energy’, ‘being in shape’ psychosocial states | Concurrent and lagged training loads positively associated with perf-related SE |
| Main et al. [ | 20 M, 10 F well-trained | Linear mixed modelling of 45 weeks of training and SAS data | Training factors, SAS | SAS associated with ↑ in training factors*. Greatest impact on SAS by psychological stressors***. Common overtraining symptoms affected by ↑ training and psychological stressors*. Mood disturbance not affected by training factors* but by ↑ in psychological stressors***. Each of the three athlete burnout subscales affected by psychological*** stressors and training factors* |
| Main and Landers [ | 1 M | Visual inspection of retrospective case study of weekly ABQ and MTDS, obtained for 45 weeks from season start, in conjunction with semi-structured interviews and consultation with sports doctor | ABQ factor 1 (reduced sense of accomplishment), ABQ factor 2 (sport devaluation), ABQ factor 3 (emotional and physical exhaustion); MTDS factors 1–6 (depression, vigour, physical signs and symptoms, sleep disturbances, perceived stress, and fatigue, respectively) | Athlete burnout and overtraining syndrome may develop simultaneously and be confused with each other |
| Plews et al. [ | 1 M, 1 F elite | Linear regression of daily HRV data obtained over 77 days for one athlete who became NFOR and one who did not | 7-day rolling average of the log-transformed square root of the mean sum of the squared differences between R-R intervals, coefficient of variation of HRV (CV of the aforementioned variable) | 7-day rolling average of the log-transformed square root of the mean sum of the squared differences between R-R intervals ↓ towards race day in NFOR athlete, remaining stable in control. In the NFOR athlete, coefficient of variation of HRV revealed large linear ↓ towards NFOR (i.e |
| Vleck [ | 8 | Prospective longitudinal training diary-based study over 26 weeks | POMS-C vigour, confusion, depression, tension and anger factor scores; difference between individual normative peak performance values and composite weekly values for resting morning HR, gastric disturbance, DOMS and heavy legs; performance decrement and injury | Probability of self-assessed performance decrement = 1/[1 − (exp (−2.68)*exp (0.75 heavy legs-DOMs score)*exp (0.298 number of standard deviations outside the peak performance composite appetite score that the score in other weeks of the analysis accounted for)* exp (0.595 POMS-C confusion score 2 weeks prior)*exp (0.383 POMS-C confusion score 2/3 weeks prior)* exp (0.528 POMS-C anger score 1-week prior)] |
| Rietjens et al. [ | 7 M, 4 F elite | 102 blood samples over 3 years | Hb, Hct, RBC, mean corpuscular Hb, mean corpuscular volume, mean corpuscular Hb content and plasma ferritin. The data were pooled and divided into three periods; off-season, training season and race season | Only RBC ↓ during race season compared with training season. Hematological values below lower limit of normal range in 46, 55, and 72 % of athletes during the off-, training- and race seasons, respectively. Hb and ferritin values most frequently < normal range. Training at 2,600 m for 3 weeks showed Hb, Hct and mean corpuscular volume |
– indicates no information, ↑ indicates increased, ↓ indicates decreased, ABQ Athlete Burnout Questionnaire, [BLA] blood lactate concentration, BP blood pressure, CK creatine kinase, CV coefficient of variation, DOMS delayed-onset muscle soreness, DBP diastolic blood pressure, EC economy, F female, FEV forced expiratory volume in 1 s, ½IM half-Ironman (i.e. 1.9-km swim, 90-km cycle, 21-km run), Hb haemoglobin, Hct haematocrit, HTT hydroxytryptamine transporter, HR heart rate, HRV heart rate variability, IL interleukin, IM Ironman, LD long distance, LDH lactate dehydrogenase, M male, MAO-A monoamine oxidase A, MAP maximal aerobic power, MTDS Multi-component Training Distress Scale, NFOR non-functionally over-reached, OD Olympic distance (i.e. 1.5-km swim, 40-km cycle, 10-km run), perf performance, PGF prostaglandin, POMS Profile of Mood States, POMS-C Profile of Mood States-C, PPO peak power output, RBC red blood cell count, RESTQ–Sport Recovery Stress Questionnaire for Athletes, RPE rating of perceived exertion, R-R interval the interval between the peak of one QRS complex to another on an electrocardiogram, SAS signs and symptoms of injury, SBP systolic blood pressure, SE self-efficacy, TPRI total peripheral resistance index, Vmax peak speed, VO peak peak oxygen uptake, VO oxygen uptake, VO max maximal oxygen uptake, VT ventilatory threshold, VT first ventilatory threshold, VT second ventilatory threshold, W(peak) peak power output
* p < 0.05, ** p < 0.02, *** p < at least 0.01
Selected limitations of the health-related triathlon literature and recommendations as to how they might be addressed
| Issue | Consensus to develop and implement | Key studies to undertake |
|---|---|---|
| Quantification of the levels of risk/training stress to which triathletes expose themselvesa,b | Universal systems of categorising subjects’ level of athletic ability and event distance specialization, for the purpose of research | How training in each of the individual triathlon disciplines, and weight training, should be weighted for the purpose of calculating total summed training load |
| Effect of training on injury, immune, oxidative and cardiovascular status | Agreement on the key issues and markers to monitor on a longitudinal prospective basis | Comparison against age-matched healthy controls |
| Investigation of possible links between oxidative and/or immunological status and illness incidence | Definition of illness | The extent to which this is influenced by transference between disciplines |
| Determination of the risks of competitiona,b,c | Universal reporting methods for race injuries and illnesses [ | Follow-up of sudden death incidents by retrospective questioning of next-of-kin for autopsy reports/pre-existing medical conditions of the athletes in questionf,g Extent to which risk of heat illness is influenced by competition length, equipment restrictions, and/or environmental conditions (such as water temperature) The extent to which injury risk and treatment duration changes with competition length and environmental conditions |
| Comparison of the outcomes of triathlon training and competition with those of untrained healthy controlsa,c | – | Incidence and short-term outcome of illness in triathletes Extent to which injury recurs Long-term sequelae of the structural and other changes to the heart that occur with triathlon training and competition Extent of sudden cardiac death in training as well as in competition |
– indicates no information
aAs modified by age, ability level and/or event-distance specialization
bAs modified by competition duration, course topography, equipment restrictions and/or environmental conditions (such as water temperature)
cIncluding for how long any such effect lasts
dMust include a definition of recurring injury, to be used in prospective studies
eMust include details of the conditions under which (and, as far as possible, how) the injury occurred. This is particularly important for research into the possible aetiology of swim-related deaths
fPerhaps incorporating a health and performance risk grading system similar to that of Dijkstra et al. [313]
gAs per Kim et al. [243]
| The sport of triathlon appears to be relatively safe for the majority of well-trained, well-prepared athletes. |
| The demands of triathlon training and racing, and their influence on injury and illness, are not well-described. |
| More prospective investigation of the health-related effects of triathlon participation, with a view to producing better training and racing guidelines, is warranted. |